To refine your search through our archives use our Advanced Search
The court noted that after the government filed a second indictment March 12, the trade-secret theft claims against Guoqing Cao and Shuyu Li were changed to wire fraud, and aiding and abetting and conspiracy to commit wire fraud.
One of the first states to adopt Common Core standards became the first state to formally abandon the national benchmarks.
When John Lechleiter was named CEO of Eli Lilly and Co. in late 2007, the Indianapolis-based drugmaker derived just 5 percent of its annual revenue from its Elanco Animal Health subsidiary. But next year, after Lilly completes its $5.4 billion acquisition of Novartis Animal Health, Elanco will contribute 17 percent of revenue—or one out of every six dollars flowing into Lilly’s coffers. It’s been a swift transformation for Greenfield-based Elanco. In the mid-2000s, Lilly employees often tried to avoid or leave posts at Elanco because its future was in doubt. “Five years ago, people said, ‘Don’t go to Elanco because they’re going to get sold,’” Elanco President Jeff Simmons said in a 2010 interview. But the 2007 decision by Lechleiter and the Lilly board to invest in Elanco turned things around. Elanco now employs 3,500 worldwide, up from 2,500 a few years ago. Elanco’s revenue has shot up from $996 million in 2007 to $2.2 billion last year—growth of 120 percent, which is three times faster than the rest of the animal health industry. Of that growth, 60 percent has come organically, as Elanco aggressively pushed its products into foreign markets to complement its strong presence in the United States. The other 40 percent has come via acquisitions. The Novartis deal, expected to close in early 2015, will be Elanco’s eighth purchase in as many years.
Two Warsaw-based orthopedic implant companies agreed to merge last week in a $13.4 billion deal. Zimmer Holdings Inc. will acquire Biomet Inc., whose private equity owners had planned to stage a public stock offering this year. Biomet posted $3.1 billion in revenue in 2013, up from $2.8 billion in 2012, according to IBJ research. It employs 9,000 people worldwide. Zimmer reported $4.6 billion in revenue in 2013. It has about 9,500 employees. “This will give Zimmer some leverage when they go to hospitals, and help them compete,” said Jason McGorman, an analyst at Bloomberg Industries in Princeton, N.J., according to a report by Bloomberg News. Also, “they get a little more in terms of products in other areas, like sports medicine, extremities and trauma, where Zimmer has less exposure.” Zimmer will pay $10.4 billion in cash and issue shares of its common stock valued at $3 billion to Biomet Inc.'s equity holders.
Eli Lilly and Co.’s drug ramucirumab won approval from U.S. regulators to be sold under the brand name Cyramza as a treatment for gastric cancer. According to Bloomberg News, analysts expect the drug could bring in annual sales of more than $1 billion. Lilly is trying to launch new cancer and diabetes drugs to offset the loss of revenue from the anti-depressant Cymbalta, which saw its U.S. patent expire in December. Lilly obtained the drug Cyramza in its acquisition of ImClone Systems Inc. in 2008. Lilly is also studying the drug in lung, liver and colorectal cancers.
Dow AgroSciences LLC reported record sales of $2.1 billion in the first quarter, an increase of 1 percent over last year's first period, the Indianapolis-based company reported April 23. The subsidiary of Midland, Mich.-based Dow Chemical Co. also reported record earnings before interest, taxes, depreciation and amortization, or EBITDA, of $529 million, up 9 percent from a year ago. Dow Agro said higher sales and lower expenses boosted profit. Sales of crop-protection products grew 4 percent overall in the quarter, mainly due to gains in foreign markets. Sales of new crop-protection products rose 28 percent. Sales of seeds and seed traits fell 7 percent in the quarter, partly due to the late planting season in the United States.
Dr. Alexia Torke, an internist, has been named associate director of the Indiana University Center for Aging Research. Torke is a researcher at the Indianapolis-based Regenstrief Institute and a professor at the IU School of Medicine. The Center for Aging Research works with scientists, clinicians, patients and others to develop and test innovative strategies to improve the quality of health care and self-care of older adults. Torke graduated from Carleton College and received a medical degree from the IU School of Medicine.
Mark Anderson has been named director of Franciscan Physician Network’s Joint Replacement Surgeons of Indiana and the Center for Hip and Knee Surgery at Franciscan St. Francis Health. Anderson, who has worked at Franciscan for 16 years, graduated from Indiana University’s physical therapy program in 1997 and earned an MBA from Indiana Wesleyan University in 2009.
The argument that the complex could help revitalize the neighborhoods near the former GM stamping plant southwest of downtown could be crucial for securing the support of residents.
The appointment of Purdue University President Mitch Daniels to the Commission on Presidential Debates raises the question of whether the university would bid to host one of the debates for the 2016 race.
Jack Ramsay, who won an NBA title with Portland and coached the Indiana Pacers from 1986 to 1988, died Monday in Naples, Fla., after battling cancer for more than 15 years, ESPN reported
Indiana residents will get a chance to weigh in on strategies for improving the state's efforts in education, job-skills training and career-development.
Stamford, Conn.-based Charter Communications said Monday that it has reached an agreement to take control of 3.9 million of Comcast’s customers under a plan that will create a new cable-TV company in most of Indiana, including Indianapolis.
The $10 million, 68-unit mixed-use apartment project at 501 Virginia Ave. will include 9,900 square feet of ground-level retail space along the Cultural Trail. Construction is set to start in mid-May.
Excluding the cost of finally shedding a block of business from predecessor Conseco Inc., CNO's operations were on the upswing in the first quarter.
What did you see, hear or do on the A&E front this weekend?
Ball State University is asking the Indiana Supreme Court to hear its challenge of a court ruling that would require it to release transcripts of students who leave the school with unpaid tuition.
Eric Turner, the first lawmaker to be investigated by the House Ethics Committee in close to two decades, is under review for his private lobbying against a proposed ban on the construction of new nursing homes.
The lawsuit is part of a movement by current and former college athletes to secure compensation, and greater medical benefits, control over their images and labor protections in a system that considers them amateurs.
The Mills House in Greenwood appeared on the list for the first time, while the Anderson Athletic Park Pool made a return appearance. Indiana Landmarks unveiled the list at its Rescue Party Saturday night.
U.S. Sen. Marco Rubio of Florida, former Pennsylvania U.S. Sen. Rick Santorum, Indiana Gov. Mike Pence and Louisiana Gov. Bobby Jindal addressed the NRA's annual leadership forum, a kind of political pep rally the organization considers one of its premier events.
The city of Indianapolis announced Friday that it is asking development teams to use part of the former GM Stamping Plant property west of downtown in its proposals for a new criminal justice center.
Indianapolis Business Journal gathered leaders in Indiana’s life sciences industry for a Power Breakfast panel discussion April 24. Among other topics, the panelists discussed whether Obamacare helps or hurts companies in the industry, the biggest barrier to life sciences startups, and how rising activity among angel investors has changed the life sciences landscape.
